Skip to content

Effect of Virtual Reality Intervention on Preoperative Anxiety and Postoperative Gastrointestinal Function Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Prospective Randomized Controlled Trial

Effect of Virtual Reality Intervention on Preoperative Anxiety and Postoperative Gastrointestinal Function Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123573
Enrollment
Unknown
Registered
2026-04-28
Start date
2026-05-06
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Intervention Group:Preoperative VR intervention in addition to routine preoperative consultation and standardized anesthesia.
Control Group:Routine preoperative consultation and standardized anesthesia only.

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.American Society of Anesthesiologists (ASA) Physical Status Classification II-III; 2.Aged >=18 years; 3.Undergoing elective laparoscopic bariatric surgery for the first time; 4.No preoperative gastrointestinal diseases; 5.Possessing basic audio-visual abilities;

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Severe mental illness (e.g. schizophrenia, acute phase of major depression) or cognitive impairment; 3. A history of motion sickness or a tendency to experience severe discomfort (nausea, dizziness) following VR exposure; 4. Recent use of medications that may significantly affect anxiety levels (e.g. benzodiazepines) or gastrointestinal motility (e.g. high-dose opioid analgesics, prokinetic agents, antiemetics) 5. Known severe vestibular dysfunction 6. Skin conditions unsuitable for wearing VR headsets 7. Participation in other intervention studies that may affect anxiety or gastrointestinal function

Design outcomes

Primary

MeasureTime frame
Time to first flatus;Anxiety score;Sleep score;Postoperative pain score;

Secondary

MeasureTime frame
Antiemetic use;Postoperative gastrointestinal function score;Time to first ambulation;Postoperative Nausea and Vomiting;Adverse events following VR intervention;Opioid consumption (morphine milligram equivalents);Emergence agitation score;Length of hospital stay;

Countries

China

Contacts

Public ContactYueying Zhang

The Affiliated Hospital of Xuzhou Medical University

Zyy0218@126.com+86 516 85802297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026